source
- Moderna and Merck cancer vaccine returns ‘landmark’ result in melanomaAt an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna shares.BioPharma Dive · 1d ago↗ source
- AstraZeneca’s Tagrisso plus Orpathys improves survival in MET-mutated lung cancerA new combination therapy using AstraZeneca’s Tagrisso together with Hutchmed’s Orpathys has shown a survival benefit for patients with a specific form of non‑small cell lung cancer. The study focu…